Skip to main content

Table 6 The impacts of UZMDP on healthcare services utilization and expenditures (FE model)

From: Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China

  Inpatient admissions Total Drug Diagnosis Laboratory Medical consumables
  Estimate Se Estimate Se Estimate Se Estimate Se Estimate Se Estimate Se
Intercept -0.309*** 0.027 6,801.300*** 222.200 3,981.000*** 166.000 -2,270.000*** 95.980 -461.000*** 28.750 -1,731.000*** 73.410
UZMDP adoption 0.248*** 0.032 669.800* 264.600 -1,338.000*** 196.500 3,099.000*** 108.900 1,299.000*** 32.680 2,055.000*** 82.980
R2 0.425 % 0.047 % 0.019 % 0.600 % 0.920 % 0.339 %
  Outpatient visits Total Drug Diagnosis Laboratory Medical consumables
  Estimate Se Estimate Se Estimate Se Estimate Se Estimate Se Estimate Se
Intercept -0.161** 0.051 -13.210 32.050 430.400*** 51.580 -648.817*** 13.379 -442.521*** 9.784 -639.507*** 14.239
UZMDP adoption 0.386*** 0.059 153.410*** 36.790 -1,516.000*** 59.160 348.593*** 11.852 189.365*** 8.212 372.503*** 13.129
R2 0.177 % 0.072 % 0.219 % 1.343 % 1.166 % 1.761 %
  1. aSignificance codes: *** ≤ 0.001, ** ≤ 0.01, * ≤ 0.05